Gene Therapy of Solid Cancers : Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Humana,
2015.
|
| Edición: | 1st ed. 2015. |
| Colección: | Methods in Molecular Biology,
1317 |
| Materias: |
Tabla de Contenidos:
- Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy
- Gene Gun Her2/neu DNA Vaccination: Evaluation Of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor Model
- MIDGE Technology for the Production of a Fourfold Gene-Modified, Allogenic Cell-Based Vaccine For Cancer Therapy
- Evaluation of Bystander Cell Killing Effects in Suicide Gene Therapy of Cancer: Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis
- Oncoleaking: Use of the Pore-forming Clostridium perfringens Enterotoxin (CPE) for Suicide Gene Therapy
- iCaspase 9 Suicide Gene System
- p53-encoding pDNA Purification by Affinity-Chromatography for Cancer Therapy
- A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a Mimic
- Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-b) Isoform mRNAs for the Treatment of Solid Tumors
- RNA Interference for Antimetastatic Therapy
- STAT3 Decoy ODN Therapy for Cancer
- Oncolytic Viral Therapy using Reovirus
- Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring
- Back To The Future: Are Tumor-Targeting Bacteria The Next Generation Cancer Therapy?
- Ethics of Cancer Gene Transfer Clinical Research
- Planning an Academic Clinical Trial
- Production of Plasmid DNA as Pharmaceutical
- Minicircle - Next Generation DNA Vectors for Vaccination
- A Phase 2, Open-Label, Randomized Study of Pexa-Vec (JX-594) Administered by Intratumoral Injection in Patients with Unresectable Primary Hepatocellular Carcinoma
- Antiangiogenic Metargidin Peptide (AMEP) Gene Therapy in Disseminated Melanoma
- Clinical Evaluation of ErbB-targeted CAR T-cells, Following Intra-Cavity Delivery in Patients with ErbB-Expressing Solid Tumors. .